Tango Therapeutics, Inc.
TNGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $70 | $66 | $60 | $143 |
| Short-Term Investments | $188 | $271 | $306 | $343 |
| Receivables | $0 | $0 | $2 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $10 | $7 | $5 |
| Total Curr. Assets | $266 | $347 | $375 | $492 |
| Property Plant & Equip (Net) | $48 | $53 | $58 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $3 | $3 | $2 |
| Total NC Assets | $50 | $56 | $61 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $316 | $403 | $436 | $500 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $4 | $3 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $18 | $26 | $32 | $26 |
| Other Curr. Liab. | $16 | $15 | $17 | $10 |
| Total Curr. Liab. | $38 | $46 | $56 | $41 |
| LT Debt | $34 | $37 | $39 | $0 |
| Deferred Rev, NC | $45 | $67 | $92 | $115 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $79 | $104 | $131 | $115 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $36 | $39 | $41 | $2 |
| Total Liabilities | $117 | $149 | $187 | $155 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$502 | -$371 | -$270 | -$161 |
| AOCI | $0 | $0 | -$4 | -$1 |
| Other Equity | $701 | $624 | $523 | $507 |
| Total Equity | $200 | $253 | $249 | $345 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $316 | $403 | $436 | $500 |
| Net Debt | -$33 | -$27 | -$19 | -$141 |